AI and software engineering partner for pharma and life sciences firms
Newpage Solutions builds custom software and AI systems for pharmaceutical, biotech and healthcare clients. Its stack centers on agent frameworks (LangGraph, AutoGen, OpenAI Assistants) plus multiple vector stores (Pinecone, Chroma, Weaviate, pgvector), pointing to a practice moving from apps toward production RAG and AI agents. Hiring is accelerating, almost entirely senior engineering, spread across Europe, India and the US.
Newpage Solutions is a privately held technology services firm founded in 2012 and headquartered in Florida, USA. It serves pharmaceutical, biotechnology and healthcare organizations with AI-driven analytics, marketing technology implementations, connected health products and patient companion apps. Delivery spans strategy, custom development, testing and deployment. The company has 51–200 employees and operates a remote-first model with engineering talent in Romania, the United Kingdom, India, Poland, Greece, Bangladesh and the United States.
Newpage uses Python, TypeScript, Next.js, React, FastAPI and Fastify, with LangGraph, AutoGen, OpenAI and Gemini for AI, vector stores like Pinecone and pgvector, and Docker, Kubernetes, AWS and Azure for infrastructure.
Yes. Hiring is accelerating and concentrated in engineering, mostly at senior, lead and staff levels, across Romania, the UK, India, Poland, Greece, Bangladesh and the US.
Current work includes production RAG systems, LLM integration and evaluation pipelines, AI agents and AI-powered features, a content supply chain integration platform, and AI experimentation sprints.
Other companies in the same industry, closest in size
Newpage Solutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.